These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36807097)

  • 1. Assessment of the use of the Magseed marker in the localization of non-palpable lesions in the mammary gland.
    Cieciorowski M; Wow T; Cieśla S; Kolacinska A; Murawa D
    Pol Przegl Chir; 2022 Oct; 95(4):1-5. PubMed ID: 36807097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the future magnetic? Magseed localisation for non palpable breast cancer. A multi-centre non randomised control study.
    Zacharioudakis K; Down S; Bholah Z; Lee S; Khan T; Maxwell AJ; Howe M; Harvey J
    Eur J Surg Oncol; 2019 Nov; 45(11):2016-2021. PubMed ID: 31288944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Accuracy of Using Magnetic Seed for Preoperative Non-Palpable Breast Lesions Localization: Our Experience with Magseed.
    D'Angelo A; Trombadori CML; Caprini F; Lo Cicero S; Longo V; Ferrara F; Palma S; Conti M; Franco A; Scardina L; D'Archi S; Belli P; Manfredi R
    Curr Oncol; 2022 Nov; 29(11):8468-8474. PubMed ID: 36354727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Seed Localization (Magseed) for excision of impalpable breast lesions-The North Wales experience.
    Powell M; Gate T; Kalake O; Ranjith C; Pennick MO
    Breast J; 2021 Jun; 27(6):529-536. PubMed ID: 33855763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience of the Magseed
    Crèvecoeur J; Jossa V; Di Bella J; Coibion M; Crèvecoeur A
    Gland Surg; 2023 May; 12(5):566-576. PubMed ID: 37284712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial experience of magnetic seed localization for impalpable breast lesion excision: First 100 cases performed in a single Irish tertiary referral centre.
    Murphy E; Quinn E; Stokes M; Kell M; Barry M; Flanagan F; Walsh SM
    Surgeon; 2022 Jun; 20(3):e36-e42. PubMed ID: 33840595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the nonradioactive inducible magnetic seed system Magseed for preoperative localization of nonpalpable breast lesions - initial clinical experience.
    Pieszko K; Wichtowski M; Cieciorowski M; Jamont R; Murawa D
    Contemp Oncol (Pozn); 2020; 24(1):51-54. PubMed ID: 32514238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introducing SentiMag in a rural setting: a 5-year experience.
    Sreedhar S; Maloney J; Hudson S
    ANZ J Surg; 2021 Nov; 91(11):2404-2410. PubMed ID: 34309147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combined, totally magnetic technique with a magnetic marker for non-palpable tumour localization and superparamagnetic iron oxide nanoparticles for sentinel lymph node detection in breast cancer surgery.
    Hersi AF; Eriksson S; Ramos J; Abdsaleh S; Wärnberg F; Karakatsanis A
    Eur J Surg Oncol; 2019 Apr; 45(4):544-549. PubMed ID: 30401506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Axillary Lymph Node Marking with Magseed® before and after Neoadjuvant Systemic Therapy in Breast Cancer Patients: MAGNET Study.
    Martínez M; Jiménez S; Guzmán F; Fernández M; Arizaga E; Sanz C
    Breast J; 2022; 2022():6111907. PubMed ID: 35855102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative localisation of nonpalpable breast lesions using magnetic markers in a tertiary cancer centre.
    Petrillo A; Di Giacomo R; Esposito E; Vallone P; Setola SV; Raso MM; Granata V; Barretta ML; Siani C; Rinaldo C; Donzelli I; Marone U; Melucci MT; Fucito A; Saponara R; Di Bonito M; Fusco R; Rinaldo M; Avino F
    Eur Radiol Exp; 2022 Jul; 6(1):28. PubMed ID: 35790602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel labeling modality of intra-abdominal lesions with Magseed magnetic marker and extirpation by Sentimag probe navigation.
    Toman D; Sengul I; Kubala O; Jonszta T; Prokop J; Tulinský L; Ihnát P; Guňková P; Pelikán A; Sengul D
    Rev Assoc Med Bras (1992); 2023; 69(1):159-163. PubMed ID: 36629655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentre evaluation of magnetic technology for localisation of non-palpable breast lesions and targeted axillary nodes.
    McCamley C; Ruyssers N; To H; Tsao S; Keane H; Poliness C; Mehta K; Rose A; Baker C; Mann GB
    ANZ J Surg; 2021 Nov; 91(11):2411-2417. PubMed ID: 34405514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The applicability of Magseed® for targeted axillary dissection in breast cancer patients treated with neoadjuvant chemotherapy.
    Reitsamer R; Peintinger F; Forsthuber E; Sir A
    Breast; 2021 Jun; 57():113-117. PubMed ID: 33813230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of Non-palpable Breast Lesions.
    Liang DH; Black D; Yi M; Luo CK; Singh P; Sahin A; Scoggins ME; Moseley TW; Hunt KK
    Ann Surg Oncol; 2022 Jun; 29(6):3822-3828. PubMed ID: 35233742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advantages of preoperative localization and surgical resection of metastatic axillary lymph nodes using magnetic seeds after neoadjuvant chemotherapy in breast cancer.
    Mariscal Martínez A; Vives Roselló I; Salazar Gómez A; Catanese A; Pérez Molina M; Solà Suarez M; Pascual Miguel I; Blay Aulina L; Ríos Gozálvez C; Julián Ibáñez JF; Rodríguez Martínez P; Martínez Román S; Margelí Vila M; Luna Tomás MA
    Surg Oncol; 2021 Mar; 36():28-33. PubMed ID: 33285433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Seed (Magseed) Localisation in Breast Cancer Surgery: A Multicentre Clinical Trial.
    Žatecký J; Kubala O; Coufal O; Kepičová M; Faridová A; Rauš K; Lerch M; Peteja M; Brát R
    Breast Care (Basel); 2021 Aug; 16(4):383-388. PubMed ID: 34602944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective, Phase IV Trial.
    Singh P; Scoggins ME; Sahin AA; Hwang RF; Kuerer HM; Caudle AS; Mittendorf EA; Thompson AM; Bedrosian I; Teshome M; DeSnyder SM; Meric-Bernstam F; Hunt KK
    Ann Surg Open; 2020 Dec; 1(2):e008. PubMed ID: 34017965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of Magseed® marking before neoadjuvant systemic therapy with subsequent contrast-enhanced mammography in patients with non-palpable breast cancer lesions after treatment: the MAGMA study.
    Bravo EI; Martínez AM; Alvà HP; Sancho DR; López JCA; Sánchez JA; Casa PE; de Las Heras CG; Venegas MAF; Vidal EG; Begines ED; Mur CG; Vicente I; Casamayor C; Cruz S; Barrado AG
    Breast Cancer Res Treat; 2024 Jun; ():. PubMed ID: 38898360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient and clinician satisfaction and clinical outcomes of Magseed compared with wire-guided localisation for impalpable breast lesions.
    Micha AE; Sinnett V; Downey K; Allen S; Bishop B; Hector LR; Patrick EP; Edmonds R; Barry PA; Krupa KDC; Rusby JE
    Breast Cancer; 2021 Jan; 28(1):196-205. PubMed ID: 32974810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.